TCL Archive FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy October 26, 2007
TCL Archive NIH Spent $181.3 Million on PR Last Year; House Probe Prompts Analysis of Spending July 12, 2013